Back to news
News
Press Release
Mon. 6 January

4th Letter to Shareholders

Share on

Discover OPM’s 4th Letter to Shareholders!

Focus on

  • ANIMUS Program
  • OPM-101: promising clinical development
  • The immuno-oncology and IBD market
  • Interviews with our independent Board members
  • Latest news and details of the OPM-201 rights takeover
Read more

Read the others news

OPM announces equity financing of up to 5 million euros
Financial
News
Press Release
Thu. 17 April

OPM announces equity financing of up to 5 million euros

Read more
OPM announces its 2024 annual results and clinical developments
Financial
News
Press Release
Thu. 3 April

OPM announces its 2024 annual results and clinical developments

Read more
OPM announces Protocol Submission for its Phase 1b/2a Study
News
Press Release
Mon. 24 March

OPM announces Protocol Submission for its Phase 1b/2a Study

Read more
Read all news

Subscribe to the OPM newsletter

Subscribe to the newsletter to not miss any news!